FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4293563313> ?p ?o ?g. }

• W4293563313 endingPage "577955" @default.
• W4293563313 startingPage "577955" @default.
• W4293563313 abstract "To investigate the expression and possible role of soluble costimulatory molecules in the treatment of refractory myasthenia gravis.Thirty-two patients with refractory myasthenia gravis were enrolled into this study and given tacrolimus 3 mg/day. At the beginning of treatment and 12 months follow-up period, clinical data were collected and recorded. The clinical classification of myasthenia gravis Foundation (MGFA) was performed. The MGFA-quantitative myasthenia gravis score (MGFA-QMGS), manual muscle test (MMT), MG activity of daily living (MG-ADL) and the activity of daily living (MG-ADL), the 15-item myasthenia gravis quality of life (MG QOL-15) and the dose change of prednisone were used to evaluate the efficacy. The expression levels of soluble costimulatory molecules and their ligands (sPD-1/sPD-L1, sICOS/sICOSL, sCD40/sCD40L), soluble CD25 and IL-2 in serum were determined by enzyme-linked immunosorbent assay (ELISA).We observed that oral administration of 3 mg tacrolimus daily for 1 year can significantly improve the clinical symptoms of patients with refractory myasthenia gravis, which is characterized by a significant reduction in clinical scores, such as QMG, MMT, ADL, MGQOL-15, and a reduction daily oral prednisolone (PSL) dose (P < 0.0001).We also found that the levels of plasma sPD-1, sCD40, IL-2 in refractory MG patients increased significantly, and those decreased significantly 12 months after tacrolimus treatment (P < 0.05). The level of sCD25 was negatively correlated with clinical severity scores (P < 0.05). After tacrolimus treatment, the level of sPD-L1 increased although there was no significant difference.Tacrolimus could relieve the symptoms of refractory MG and significantly decrease the levels of plasma sPD-1, sICOSL, sCD40, sCD25 and IL-2. Soluble costimulatory molecules might be potential biomarkers for MG and tacrolimus treatment." @default.
• W4293563313 created "2022-08-30" @default.
• W4293563313 creator A5002117291 @default.
• W4293563313 creator A5023460508 @default.
• W4293563313 creator A5037410853 @default.
• W4293563313 creator A5039482364 @default.
• W4293563313 creator A5045032728 @default.
• W4293563313 creator A5045268007 @default.
• W4293563313 creator A5048740840 @default.
• W4293563313 creator A5084457916 @default.
• W4293563313 date "2022-11-01" @default.
• W4293563313 modified "2023-09-27" @default.
• W4293563313 title "Effect of tacrolimus on soluble costimulatory molecules in patients with refractory myasthenia gravis" @default.
• W4293563313 cites W1564765245 @default.
• W4293563313 cites W1626388077 @default.
• W4293563313 cites W1979696790 @default.
• W4293563313 cites W1981598898 @default.
• W4293563313 cites W2004883447 @default.
• W4293563313 cites W2024255166 @default.
• W4293563313 cites W2034919646 @default.
• W4293563313 cites W2062549560 @default.
• W4293563313 cites W2065357689 @default.
• W4293563313 cites W2066571580 @default.
• W4293563313 cites W2068701781 @default.
• W4293563313 cites W2080343151 @default.
• W4293563313 cites W2097855813 @default.
• W4293563313 cites W2137544340 @default.
• W4293563313 cites W2557504648 @default.
• W4293563313 cites W2782313181 @default.
• W4293563313 cites W2789644345 @default.
• W4293563313 cites W2795636185 @default.
• W4293563313 cites W2889427571 @default.
• W4293563313 cites W2898567584 @default.
• W4293563313 cites W2964980835 @default.
• W4293563313 cites W2990909659 @default.
• W4293563313 cites W3023090111 @default.
• W4293563313 cites W3038213731 @default.
• W4293563313 cites W3042794200 @default.
• W4293563313 cites W3089036232 @default.
• W4293563313 cites W3103029290 @default.
• W4293563313 cites W4211188347 @default.
• W4293563313 doi "https://doi.org/10.1016/j.jneuroim.2022.577955" @default.
• W4293563313 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36054935" @default.
• W4293563313 hasPublicationYear "2022" @default.
• W4293563313 type Work @default.
• W4293563313 citedByCount "0" @default.
• W4293563313 crossrefType "journal-article" @default.
• W4293563313 hasAuthorship W4293563313A5002117291 @default.
• W4293563313 hasAuthorship W4293563313A5023460508 @default.
• W4293563313 hasAuthorship W4293563313A5037410853 @default.
• W4293563313 hasAuthorship W4293563313A5039482364 @default.
• W4293563313 hasAuthorship W4293563313A5045032728 @default.
• W4293563313 hasAuthorship W4293563313A5045268007 @default.
• W4293563313 hasAuthorship W4293563313A5048740840 @default.
• W4293563313 hasAuthorship W4293563313A5084457916 @default.
• W4293563313 hasConcept C121332964 @default.
• W4293563313 hasConcept C126322002 @default.
• W4293563313 hasConcept C142424586 @default.
• W4293563313 hasConcept C2776715498 @default.
• W4293563313 hasConcept C2778105408 @default.
• W4293563313 hasConcept C2778720950 @default.
• W4293563313 hasConcept C2909675724 @default.
• W4293563313 hasConcept C2911091166 @default.
• W4293563313 hasConcept C71924100 @default.
• W4293563313 hasConcept C87355193 @default.
• W4293563313 hasConcept C90924648 @default.
• W4293563313 hasConceptScore W4293563313C121332964 @default.
• W4293563313 hasConceptScore W4293563313C126322002 @default.
• W4293563313 hasConceptScore W4293563313C142424586 @default.
• W4293563313 hasConceptScore W4293563313C2776715498 @default.
• W4293563313 hasConceptScore W4293563313C2778105408 @default.
• W4293563313 hasConceptScore W4293563313C2778720950 @default.
• W4293563313 hasConceptScore W4293563313C2909675724 @default.
• W4293563313 hasConceptScore W4293563313C2911091166 @default.
• W4293563313 hasConceptScore W4293563313C71924100 @default.
• W4293563313 hasConceptScore W4293563313C87355193 @default.
• W4293563313 hasConceptScore W4293563313C90924648 @default.
• W4293563313 hasLocation W42935633131 @default.
• W4293563313 hasLocation W42935633132 @default.
• W4293563313 hasOpenAccess W4293563313 @default.
• W4293563313 hasPrimaryLocation W42935633131 @default.
• W4293563313 hasRelatedWork W2011790653 @default.
• W4293563313 hasRelatedWork W2016089076 @default.
• W4293563313 hasRelatedWork W2060185678 @default.
• W4293563313 hasRelatedWork W2084122630 @default.
• W4293563313 hasRelatedWork W2133822197 @default.
• W4293563313 hasRelatedWork W2152841592 @default.
• W4293563313 hasRelatedWork W2412880888 @default.
• W4293563313 hasRelatedWork W32695660 @default.
• W4293563313 hasRelatedWork W2774672238 @default.
• W4293563313 hasRelatedWork W2783750611 @default.
• W4293563313 hasVolume "372" @default.
• W4293563313 isParatext "false" @default.
• W4293563313 isRetracted "false" @default.
• W4293563313 workType "article" @default.